<a href=\"/content/nemours/us/en.html\">91大神 Children's Health</a> | <a href=\"https://kidshealth.org/\">91大神 KidsHealth</a> </p>\r\n"}} id=text-b0f8b48d01 class=cmp-text>
Dasatinib Added to Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive Leukemia (ALL)
Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神 Children's<br>\r\n<b>Locations:</b> Delaware Valley</p>\r\n<h3>Trial Name</h3>\r\n<p>A Phase 2 Multicenter Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)</p>\r\n<h3>What is the trial about?</h3>\r\n<p>To look at the survival rate when a drug called dasatinib is added to standard chemotherapy.</p>\r\n<h3>Who can participate?</h3>\r\n<p>Age > 1 year and < 18</p>\r\n<h3>What is involved?</h3>\r\n<p>Length of study is approximately 7 years. Tests and procedures to be done include: Review of medical history; Complete physical exam; Assessment of performance status; Chest X-ray; ECG; ECHO); Collection of blood and urine samples; Spinal tap; DXA; minimal residual disease test; pregnancy test.</p>\r\n"}} id=text-0fae6a7357 class=cmp-text>
Clinical Trial
Offered by: 91大神 Children's
Locations: Delaware Valley
Trial Name
A Phase 2 Multicenter Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
What is the trial about?
To look at the survival rate when a drug called dasatinib is added to standard chemotherapy.
Who can participate?
Age > 1 year and < 18
What is involved?
Length of study is approximately 7 years. Tests and procedures to be done include: Review of medical history; Complete physical exam; Assessment of performance status; Chest X-ray; ECG; ECHO); Collection of blood and urine samples; Spinal tap; DXA; minimal residual disease test; pregnancy test.
Contact 91大神 Children's Clinical Trials
<strong>Trial Name:</strong> A Phase 2 Multicenter Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)</p>\r\n<p><strong>COG#:</strong> AALL1122</p>\r\n"}} id=text-21a968cbdb class=cmp-text>
Trial Name: A Phase 2 Multicenter Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
COG#: AALL1122
Is a Clinical Trial Right for Your Child?</h2>"}} id=text-e7ebbb22b9 class=cmp-text>
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.</p>\r\n"}} id=text-3c53e12c88 class=cmp-text>
Learn more about clinical trials and get answers to questions you might have.
